Phase II trial of taxol in patients with metastatic renal cell carcinoma

Avi I. Einzig, Elizabeth Gorowski, Jill Sasloff, Peter H. Wiernik

Research output: Contribution to journalArticle

37 Scopus citations

Abstract

Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

Original languageEnglish (US)
Pages (from-to)133-136
Number of pages4
JournalCancer Investigation
Volume9
Issue number2
DOIs
StatePublished - Jan 1 1991

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Phase II trial of taxol in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this